Furthermore, we have also highlighted the prognostic significance of HER family expression in CRC, reporting that co-expression of EGFR and HER4 correlates with poorer disease-free survival in advanced-stage CRC patients, indicating their potential as prognostic biomarkers [163]. This evidence concerns the gene ERBB4 and colorectal carcinoma.